Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Smith Patrick F, Président, Développement Intégré des Médicaments. Director active across 2 companies, notably Certara, Inc.. Aggregated, 13 disclosures have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €989k. Activity tracked since 1 November 2021. The latest transaction was filed on 7 October 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Smith Patrick F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
SMITH PATRICK F is a Président, Développement Intégré des Médicaments, associated with Certara, Inc. (XNAS). The declarant has 13 filings in total. In the sampled recent filings from 2021-11-01 to 2024-10-08, there were only sales, for a total of EUR 988961.